- Home
- DOCS vs PEN Comparison
DOCS vs PEN Comparison
Compare DOCS & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOCS | PEN |
|---|---|---|
| Founded | 2010 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 10.9B |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | DOCS | PEN |
|---|---|---|
| Price | $46.10 | $299.66 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 16 |
| Target Price | $68.05 | ★ $307.19 |
| AVG Volume (30 Days) | ★ 2.7M | 479.9K |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 42.88 | ★ 367.34 |
| EPS | 1.25 | ★ 4.14 |
| Revenue | $621,329,000.00 | ★ $1,333,798,000.00 |
| Revenue This Year | $15.22 | $16.77 |
| Revenue Next Year | $11.03 | $14.12 |
| P/E Ratio | ★ $36.78 | $72.65 |
| Revenue Growth | ★ 20.21 | 14.61 |
| 52 Week Low | $45.29 | $221.26 |
| 52 Week High | $85.21 | $310.00 |
Technical Indicators
Market Signals| Indicator | DOCS | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 28.80 | 67.77 |
| Support Level | $50.10 | $284.95 |
| Resistance Level | $51.80 | $298.69 |
| Average True Range (ATR) | 2.18 | 8.02 |
| MACD | 0.49 | 0.11 |
| Stochastic Oscillator | 9.53 | 91.50 |
Price Performance
Historical ComparisonAbout DOCS Doximity Inc.
Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.